Kaposi's sarcoma: new topical treatment approved.
James
J S
JS
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000287:Administration, Topical; D000970:Antineoplastic Agents; D003879:Dermatologic Agents / Q000191:economics / Q000627:therapeutic use; D017277:Drug Approval; D005782:Gels; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014212:Tretinoin / Q000191:economics / Q000627:therapeutic use*; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D005782:Gels; D014212:Tretinoin